Radiotherapy in locally advanced & metastatic NSC lung cancer
|
|
|
- Edith Black
- 10 years ago
- Views:
Transcription
1 Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital.
2 Locally advanced lung cancer Results of randomised trail indicate the chemo radiotherapy is the standard care of locally advanced lung cancer. Fatal toxicity uncommon after CT-RT but morbidity can be high in unselected cases. Local control is suboptimal New RT techniques permit improved local control
3 WBRG/LRH work load. ( )
4 WBRG/ LRH
5 Stage III Lung cancer Treatment of stage III NSCLC remains a very difficult and controversial area mainly because of the large heterogeneity of different pathological conditions that are still included in stage III disease.
6 Outcomes of stage III NSCLC in D RT Treatment Arms Median survival 5 years survival Standard RT 60Gy/30Fr. 1 Fr/day 11.4 months 5% Hyperfractionated RT 69.9Gy 2 Fr /day 12 months 6% Sequential CT-RT CisPla VBL +60Gy 13.2 months 8%
7 Concurrent chemo RT Median survival in phase three trials of Chemo RT 22.2 months Albain months Curan 2002, Movsas 2005
8 Concurrent or sequential RT Concurrent CT-RT reduces the risk of death at 2 years. (RR 0.8:,95 CI 0.78 to 0.95: P=.003) but at the expense of increased toxicity) Choice of optimal CT regime remains unclear. Uncertainties about true magnitude of benefit for concurrent CT RT.
9 Advances in Radiotherapy planning
10 Advanced technology. Improved the staging Improved the compliance to treatment Reduced the toxicity Marginal improvement in overall survival
11 Stage IIIA Groups T1a,b T2a, b T3 N1,2 T4 N0 N1
12 Early stage and locally advanced (non-metastatic) non-small-cell lung cancer. Treatment Protocols One size does not fit all.
13 Selection of stage IIIA patients for radical treatment Age ideally <80 Performance status. ECOG 1-2 No severe obstructive airway disease Not more than 10% body weight loss. Ideally less than 5 cm primary tumour Ideally 1-2 mediastinal nodal sites are involved. Less than 5cm distance between primary and nodal metastasis.
14 Normal tissue tolerance Lung tolerance V20 <30% V30<20% Mean lung dose <15Gy Spinal cord <45 Gy Oesophagus <11 cm Heart V40 < 35Gy
15 Clinical scenario 1 84 year old male with bad COPD. medically inoperable Ad Ca lung T1N2 disease PET
16 Stereotactic radiotherapy
17 .
18 Bulky Primary disease PET Findings 44 year man with bulky primary disease invading the mediastinum. Ad Ca
19 T4N2 M0.
20 Response
21 Clinical Scenario 3 67 year old fit asymptomatic lady presented with bulky T2N2 MO NSCLC Treatment options Discussed in MDM ( Deemed inoperable) Radical chemo radiotherapy Induction chemo followed by radical RT Palliative Chemo
22 Surgery Stage III disease
23 Surgery stage III disease
24 Yes we can burn that tumour Role of Radiation Oncologist with locally advanced and metastatic lung cancer Yes we can
25 Treatment plan
26 Response
27 Role of induction chemotherapy prior to concurrent treatment Cancer and Leukemia Group B 39801,
28 Median Survival Cancer and Leukemia Group B 39801, Induction Chemo + CRT 14months (95%CI 11 to16 months) CRT 12 months (95%CI 10 to16 months 2 year survival 31months(95% CI 25 to 38%) 29 months(95% CI 22 to 35%) Toxicity Gr 3 & 4 28 &8% 30& 2%
29 Role of induction chemotherapy prior to concurrent chemo RT J Clin Oncol May 1;25(13):
30 Neo adjuvant
31 Response after induction Chemo.
32 Response after induction Chemo
33 Complications Late Early Radiation Pneumonitis. Radiation fibrosis of the lung, oesophageal stricture. Radiation mylities. Tiredness, Acute exacerbation symptoms, odynophagia
34 Early Palliative Care for Patients with Metastatic Non Small-Cell Lung Cancer Conclusion Among patients with metastatic nonsmall-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival.
35 Palliative radiotherapy Radiotherapy plays an important role in palliative medicine. Around 20-25% of patients are on palliative treatment at any time in any Radiation Oncology Dept.
36 Indication Pain relief from bone mets. Prevention of pathological # Spinal cord compression. Impending or actual obstruction hollow viscera. Brain mets. Control of Haemoptysis. Superior Vena caval obstruction.
37 Spinal cord compression These are common symptoms: Pain and stiffness in the neck, back, or lower back Numbness, cramping, or weakness in the arms, hands, or legs Loss of sensation Difficulty with hand coordination "Foot drop," weakness in a foot that causes a limp Loss of sexual ability Loss of bladder/ bowel control.
38 Spinal cord compression Poor prognostic factors Complete paraplegia. Loss of Sphincter control. Rapid onset of symptoms ( Infarction).
39 Immediate action Dexamethasone tablets 8 mag start followed by 4 mg BD. Urgent MRI (If the facilities are available) Immediate referral to a tertiary hospital. Early treatment intervention likely to improve the out come.
40 Metastatic Spinal cord compression.
41 Superior Vena Caval Obstruction Management High dose corticosteroids. Radiotherapy to the mediastinum. Superior Venacaval stenting. Chemotherapy (Sensitive tumors like - Lymphomas, Small cell lung cancer, Seminomas, Round cell tumor
42 Brain Metastasis Management- Solitary Brain Metastasis- (Confirmed after an MRI scan) Good performance status Controlled extra cranial disease Peripheral lesions No significant co. morbid conditions, Surgical excision could be an option
43 Brain Mets (Multiple ) Treatment Surgical excision of the largest lesion improves neurological deficit and quality of life. Followed by whole brain palliative radiotherapy.
44 Brain Metastasis- Radiotherapy Palliative whole brain Radiotherapy. Stereotactic Radiotherapy for a solitary or couple of lesions. Radiotherapy to the whole brain following excision of the solitary lesion.
45 Stereotactic Radiosurgery
46 Bone Metastasis Pain Hypercalcemia Pathological # Spinal cord compression
47 Pathological Fracture when > 50% of the cortex is destroyed, the fracture rate increases up to 80%
48 Pathological # Needs Surgical fixation before Radiotherapy.
49 At MDM we make Taylor made outfits.
50 Thank you.
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Background The Cancer Institute New South Wales Oncology Group Lung (NSWOG Lung) identified the need for the development
Management of spinal cord compression
Management of spinal cord compression (SUMMARY) Main points a) On diagnosis, all patients should receive dexamethasone 10mg IV one dose, then 4mg every 6h. then switched to oral dose and tapered as tolerated
Radiation Therapy in the Treatment of
Lung Cancer Radiation Therapy in the Treatment of Lung Cancer JMAJ 46(12): 537 541, 2003 Kazushige HAYAKAWA Professor and Chairman, Department of Radiology, Kitasato University School of Medicine Abstract:
Lung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
Radiotherapy in Plasmacytoma and Myeloma. David Cutter Multiple Myeloma NSSG Annual Meeting 14 th September 2015
Radiotherapy in Plasmacytoma and Myeloma David Cutter Multiple Myeloma NSSG Annual Meeting 14 th September 2015 Contents Indications for radiotherapy: Palliation in Multiple Myeloma Solitary Bone Plasmacytoma
Management of Non-Small Cell Lung Cancer Guide for General Practitioners
Management of n-small Cell Lung Cancer Guide for General Practitioners Clinical Stage I Cancer only in one lobe of lung and
Stage I, II Non Small Cell Lung Cancer
Stage I, II Non Small Cell Lung Cancer Best Results T1 (less 3 cm) N0 80% 5 year survival No Role Adjuvant Chemotherapy Radiation Therapy Reduces Local Recurrence No Improvement in Survival 1 Staging Mediastinal
Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
Case Number: RT2009-124(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Renal Cell Carcinoma of the Left Kidney Post Radical Surgery with pt4 Classification with Multiple Lung and Single Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-124(M)
MALIGNANT SPINAL CORD COMPRESSION. Kate Hamilton Head of Medical Oncology Ballarat Health Services
MALIGNANT SPINAL CORD COMPRESSION Kate Hamilton Head of Medical Oncology Ballarat Health Services OVERVIEW Background Epidemiology Pathophysiology Diagnosis Investigation Differential Diagnosis Management
Small Cell Lung Cancer
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); [email protected] Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation
SMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof.
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof. Alberto Riccardi SMALL CELL LUNG CARCINOMA Summary of treatment approach * limited
Multiple Myeloma with Pathologic Fracture: the Role and Treatment Consideration of RT
Multiple Myeloma with Pathologic Fracture: the Role and Treatment Consideration of RT Case Number: RT2009-37(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor Purpose: to present
Acute Oncology Service Patient Information Leaflet
Spinal cord compression Acute Oncology Service Patient Information Leaflet Introduction If you have been diagnosed with cancer, you need to know about spinal cord compression and the warning signs. What
Current Status and Perspectives of Radiation Therapy for Breast Cancer
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
METASTASES TO THE BONE
RADIATION THERAPY FOR METASTASES TO THE BONE Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY WHAT ARE BONE METASTASES? Cancer that starts
Case Number: RT2009-114(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Extensive-Stage Small Cell Lung Cancer Post Full-Course Chemotherapy with Residual Locoregional Cancer Disease: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-114(M) Potential
Clinical Management Guideline Management of locally advanced or recurrent Renal cell carcinoma. Protocol for Planning and Treatment
Protocol for Planning and Treatment The process to be followed in the management of: LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA Patient information given at each stage following agreed information
Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015
Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3
University College Hospital. Metastatic spinal cord compression (MSCC) information for patients at risk of developing MSCC.
University College Hospital Metastatic spinal cord compression (MSCC) information for patients at risk of developing MSCC Cancer Services 2 If you would like this document in another language or format,
Management of stage III A-B of NSCLC. Hamed ALHusaini Medical Oncologist
Management of stage III A-B of NSCLC Hamed ALHusaini Medical Oncologist Global incidence, CA cancer J Clin 2011;61:69-90 Stage III NSCLC Includes heterogeneous group of patients with differences in the
A new score predicting the survival of patients with spinal cord compression from myeloma
A new score predicting the survival of patients with spinal cord compression from myeloma (1) Sarah Douglas, Department of Radiation Oncology, University of Lubeck, Germany; [email protected] (2) Steven
Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA
THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301
PRIMARY GLIOMA (oligodendroglioma, astrocytoma, oligodendroglioma, oligoastrocytoma, including anaplastic, gliosarcoma and glioblastoma multiforme)
Protocol for Planning and Treatment The process to be followed when a course of chemotherapy is required to treat: PRIMARY GLIOMA (oligodendroglioma, astrocytoma, oligodendroglioma, oligoastrocytoma, including
7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.
Dictionary Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment. Applicator A device used to hold a radioactive source
Lung cancer forms in tissues of the lung, usually in the cells lining air passages.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
Lung cancer case study
Change Presentation title and date in Footer dd.mm.yyyy Lung cancer case study Dr Jaishree Bhosle Consultant Medical Oncologist Change Presentation title and date in Footer dd.mm.yyyy 1 2 Part One Initial
Helical TomoTherapy for Lung Cancer Radiotherapy: Good Science Pays Clinical Dividends Peter Hoban, Ph.D., TomoTherapy Inc.
CLINICAL FEATURE Helical TomoTherapy for Lung Cancer Radiotherapy: Good Science Pays Clinical Dividends Peter Hoban, Ph.D., TomoTherapy Inc. The Challenge Lung cancer kills more people each year in the
Alternatives to Surgical Resection for Early Stage Lung Cancer
Alternatives to Surgical Resection for Early Stage Lung Cancer Neil A. Christie MD University of Pittsburgh Medical Center Department of Thoracic Surgery Allied Health Personnel Symposium AATS 2014 Conflicts
the standard of care 2009 5/1/2009 Mesothelioma: The standard of care take home messages PILC 2006 [email protected] Brussels, March 7, 2009
Mesothelioma: The standard of care [email protected] Brussels, March 7, 2009 take home messages PILC 2006 All patients should receive adequate palliation of dyspnea and pain before starting chemotherapy
4.2 Spinal Cord Compression
4.2 Spinal Cord Compression AO Protocol Name: Metastatic Spinal Cord Compression (MSCC) AO Type: Type I (New Cancer), Type III (Cancer Complication) Author: ST Introduction: MSCC can cause irreversible
Radiation Fibrosis Fact Sheet
Radiation Fibrosis Fact Sheet What is Radiation Fibrosis Syndrome (RFS), and when can it occur? Radiation Fibrosis Syndrome (RFS) is a term used to describe the multiple clinical symptoms associated with
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James
RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting September 14, 2011 1 Review Team Paul G. Kluetz,
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
Metastatic Breast Cancer: The Art and Science of Systemic Therapy. Vallerie Gordon MD, FRCPC Medical Oncologist CancerCare Manitoba
Metastatic Breast Cancer: The Art and Science of Systemic Therapy Vallerie Gordon MD, FRCPC Medical Oncologist CancerCare Manitoba Presenter Disclosure Faculty: Dr. Vallerie Gordon Relationships with commercial
بسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
Lung cancer (non-small-cell)
Patient information from the BMJ Group Lung cancer (non-small-cell) It can be devastating to find out that you or someone close to you has lung cancer. You will have to make some important decisions about
Controversies in Management of. Inoperable NSCLC. Inoperable NSCLC. Introduction:
Inoperable NSCLC Controversies in Management of Inoperable NSCLC Introduction: It is difficult to overemphasize the magnitude of lung cancer as Public Health Problem in our society. - In US, Lung cancer
Radioterapia panencefalica. Umberto Ricardi
Radioterapia panencefalica Umberto Ricardi Background Systemic disease to the brain is unfortunately a quite common event Radiotherapy, especially with the great technical development during the past decades,
a commitment in their practice to the roles and responsibilities of clinical oncologists X
CLINICAL ONCOLOGY BLUEPRINT OF ASSESSMENT SYSTEM Good Medical Practice areas of curriculum - ST5 (Intermediate) Standards GMP criterion Workplace based assessment By the end of the third year of training
Access to over 53,000 of the world s leading medical experts, from your first day of cover.
For customers Friends Life Individual Protection providing access to Best Doctors Access to over 53,000 of the world s leading medical experts, from your first day of cover. A second medical opinion could
Please see the LUCADA data manual v3.1.3, available in the downloads section
National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands
CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014
Background CMScript Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Prostate cancer is second only to lung cancer as the leading cause of cancer-related deaths in men. It is
Radiation Therapy for Non-Small Cell Lung Cancer. Principles of Radiation Therapy for Non-small Cell Lung Cancer
Chapter 4 Radiation Therapy for Non-Small Cell Lung Cancer Join Y. Luh, MD, FACP and Charles R. Thomas, Jr., MD Introduction Radiation is a form of energy that has both beneficial and harmful effects on
Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC
Lung Cancer B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC EPIDEMIOLOGY The estimated incidence of lung cancer in Canada for 2007 is 23,300 with 12,400 occurring in
POLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES.
PATIENT INFORMATION ABOUT ADJUVANT THERAPY AFTER THE WHIPPLE OPERATION FOR ADENOCARCINOMA ( CANCER ) OF THE PANCREAS AND RELATED SITES. Radiation Oncology Sidney Kimmel Cancer Center at Johns Hopkins Last
AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life and Pensions Limited
AA Life Insurance is provided by Friends Life and Pensions Limited What would be the first thing you might think about if you were diagnosed with a serious illness? 2 It is very likely that the first thing
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life Limited
AA Life Insurance is provided by Friends Life Limited What would be the first thing you might think about if you were diagnosed with a serious illness? It is very likely that the first thing you might
PET/CT in Lung Cancer
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
Surgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW
The treatment you receive will depend on your lung cancer type, for example, whether you have a non-small cell lung cancer Adenocarcinoma or Squamous cell carcinoma, and if this is a sub-type with a mutation.
ROLE OF RADIATION THERAPY FOR RESECTABLE LUNG CANCER
AFA 08958 From Bench to Bedside From KK DT1 10/27/2015 12:04 PM 01 ROLE OF RADIATION THERAPY FOR RESECTABLE LUNG CANCER Hak Choy, MD University of Texas Southwestern Medical Center Dallas, Texas, USA Orchestrating
The Brain and Spine CenTer
The Br ain and Spine Center Choosing the right treatment partner is important for patients facing tumors involving the brain, spine or skull base. The Brain and Spine Center at The University of Texas
Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda
Stomach (Gastric) Cancer Prof. M K Mahajan ACDT & RC Bathinda Gastric Cancer Role of Radiation Layers of the Stomach Mucosa Submucosa Muscularis Serosa Stomach and Regional Lymph Nodes Stomach and Regional
Principal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center
Protocol 1101-1088 Phase I study of intra-pleural administration of GL-ONC1 in patients with malignant pleural effusion: primary, metastases and mesothelioma Principal Investigator: Valerie W. Rusch, MD,
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,
The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in Breast Cancer
BIT's 4th World Cancer Congress 2011 People s Republic of China Dalian The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in treated with DBM therapy Retrospective observational
Myeloma pathways to diagnosis UCLP audit
Myeloma pathways to diagnosis UCLP audit Dr Neil Rabin Consultant Haematologist University College London Hospitals & North Middlesex University Hospital Myeloma Clinical Features Bone pain (70%) High
Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla
Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy
Veterinary Oncology: The Lumps We Hate To Treat
Veterinary Oncology: The Lumps We Hate To Treat Michelle Turek, DVM, DACVIM (Oncology), DACVR (Radiation Oncology) College of Veterinary Medicine University of Georgia Athens, GA Veterinary Oncology Veterinary
Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female
SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. IV. THERAPY. I. NON SMALL CELL LUNG CANCER Prof.
Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA 2010-2011 LUNG CANCER. IV. THERAPY. I. NON SMALL CELL LUNG CANCER Prof. Alberto Riccardi TREATMENT OF LUNG CARCINOMA * overall treatment approach to
.org. Metastatic Bone Disease. Description
Metastatic Bone Disease Page ( 1 ) Cancer that begins in an organ, such as the lungs, breast, or prostate, and then spreads to bone is called metastatic bone disease (MBD). More than 1.2 million new cancer
Current Status and Future Direction of Proton Beam Therapy
Current Status and Future Direction of Proton Beam Therapy National Cancer Center Hospital East Division of Radiation Oncology and Particle Therapy Tetsuo Akimoto Comparison of status of particle therapy
REPORT ASCO 1998 LOS ANGELES : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group
REPORT ASCO 1998 LOS ANGELES : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group Educational session Treatment of stage III non-small cell lung cancer (NSCLC) in
LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis
LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the
MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)
MALIGNANT LYMPHOMAS Dr. Olga Vujovic (Updated August 2010) Malignant lymphomas consist of Hodgkin and non-hodgkin lymphomas. The current management of these diseases involves a multi-disciplinary approach.
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet
Overview of Gynaecologic Cancer
Overview of Gynaecologic Cancer Stuart Salfinger Gynaecologic Oncologist St John of God Hospital King Edward Memorial Hospital Cervical Cancer Cervical Cancer Risk HPV Smoking?OCP Cervical Cancer Symptoms
Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012
Radiation Oncology Nursing Care Helen Lusby Radiation Oncology Nurse BAROC 2012 Definitions Radiation Therapy: Treatment of cancer using x- ray particles that cause ionisation within the cells. External
Level 1. Nutrition & Lifestyle Oncology Certificate
Level 1 Nutrition & Lifestyle Oncology Certificate ONE MODULE 1 A Cancer Diagnosis Learn what cancer is; how/why it develops; diagnostic tests; inflammatory/ hormonal connections; 5 most important steps
Hospice and Palliative Medicine
Hospice and Palliative Medicine Maintenance of Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills
Maintenance therapy in in Metastatic NSCLC. Dr Amit Joshi Associate Professor Dept. Of Medical Oncology Tata Memorial Centre Mumbai
Maintenance therapy in in Metastatic NSCLC Dr Amit Joshi Associate Professor Dept. Of Medical Oncology Tata Memorial Centre Mumbai Definition of Maintenance therapy The U.S. National Cancer Institute s
Treatment of Small Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians (ACCP) Guideline
Treatment of Small Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians (ACCP) Guideline An ASCO Endorsement of Treatment of Small Cell Lung Cancer:
